Addressing Therapeutic Inertia: Development and Implementation of an Electronic Health Record–Based Diabetes Intensification Tool
Open Access
- 14 September 2022
- journal article
- research article
- Published by American Diabetes Association in Diabetes Spectrum
- Vol. 36 (2) , 161-170
Abstract
Objective: To assess whether an electronic health record (EHR)-based diabetes intensification tool can improve the rate of A1C goal attainment among patients with type 2 diabetes and an A1C ≥8%. Methods: An EHR-based tool was developed and sequentially implemented in a large, integrated health system using a four-phase, stepped-wedge design (single pilot site [phase 1] and then three practice site clusters [phases 2–4]; 3 months/phase), with full implementation during phase 4. A1C outcomes, tool usage, and treatment intensification metrics were compared retrospectively at implementation (IMP) sites versus nonimplementation (non-IMP) sites with sites matched on patient population characteristics using overlap propensity score weighting. Results: Overall, tool utilization was low among patient encounters at IMP sites (1,122 of 11,549 [9.7%]). During phases 1–3, the proportions of patients achieving the A1C goal (<8%) were not significantly improved between IMP and non-IMP sites at 6 months (range 42.9–46.5%) or 12 months (range 46.5–53.1%). In phase 3, fewer patients at IMP sites versus non-IMP sites achieved the goal at 12 months (46.7 vs. 52.3%, P = 0.02). In phases 1–3, mean changes in A1C from baseline to 6 and 12 months (range −0.88 to −1.08%) were not significantly different between IMP and non-IMP sites. Times to intensification were similar between IMP and non-IMP sites. Conclusion: Utilization of a diabetes intensification tool was low and did not influence rates of A1C goal attainment or time to treatment intensification. The low level of tool adoption is itself an important finding highlighting the problem of therapeutic inertia in clinical practice. Testing additional strategies to better incorporate, increase acceptance of, and improve proficiency with EHR-based intensification tools is warranted.Keywords
All Related Versions
Funding Information
- Merck
This publication has 23 references indexed in Scilit:
- Clinical Inertia in Type 2 Diabetes Management: Evidence From a Large, Real-World Data SetDiabetes Care, 2018
- Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of PhysiciansAnnals of Internal Medicine, 2018
- Prescriber response to computerized drug alerts for electronic prescriptions among hospitalized patientsInternational Journal of Medical Informatics, 2017
- Intensification of Diabetes Therapy and Time Until A1C Goal Attainment Among Patients With Newly Diagnosed Type 2 Diabetes Who Fail Metformin Monotherapy Within a Large Integrated Health SystemDiabetes Care, 2016
- Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributorsPatient Preference and Adherence, 2016
- Clinical Inertia in People With Type 2 DiabetesDiabetes Care, 2013
- Developing CollaboRATE: A fast and frugal patient-reported measure of shared decision making in clinical encountersPatient Education and Counseling, 2013
- Treatment intensification in patients with type 2 diabetes who failed metformin monotherapyDiabetes, Obesity and Metabolism, 2011
- Overrides of Medication Alerts in Ambulatory CareArchives of internal medicine (1960), 2009
- Delay Of Insulin Addition To Oral Combination Therapy Despite Inadequate Glycemic ControlJournal of General Internal Medicine, 2007